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Abstract
Background: We investigated the association between self-reported skirt size (SS) and change in SS, and incidence
of chronic liver disease (CLD) in a prospective cohort study of women recruited to the UKCTOCS trial.
Methods: Women recruited to UKCTOCS in England without documented CLD self-reported their current UK SS
during trial participation and were asked to recall their SS when aged in 20s (via completion of a questionnaire
3–5 years after recruitment). Participants were followed up via electronic health record linkage and hazard ratios
(HR) calculated for incident liver-related events (LRE).
Results: Three hundred twenty-two (0.3%) of 94,124 women experienced a first LRE. Compared to SS ≤ 16, rates
of LRE were higher in the SS ≥ 18 groups (both when aged in 20s and at questionnaire completion). Event rates
were higher if there was no change in SS or an increase in SS, compared to a decrease in SS.
In the models adjusted for potential confounders, HRs for LRE were higher in the groups of women reporting
SS ≥ 18 both when aged in 20s (HR = 1.39 (95% CI; 0.87–2.23)) and at questionnaire completion (HR = 1.37 (95%
CI; 1.07–1.75)). Compared to a decrease in SS, HRs were higher in the no change (HR = 1.78 (95% CI; 0.95–3.34))
and increase (HR = 1.80 (95% CI; 1.01–3.21)) groups.
Conclusion: CLD is associated with high SS and an increase in SS over time. These data suggest SS can be
used in simple public health messages about communicating the risk of liver disease.
Trial Registration: UKCTOCS is registered as an International Standard Randomised Controlled Trial, number
ISRCTN22488978. Registered 06/04/2000.
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Background
Chronic liver disease (CLD) is a leading cause of death
in the UK. It is estimated that 60,000 people in the UK
have cirrhosis [1, 2] but over half of those affected are
unaware of the diagnosis [3]. The main causes of CLD are
alcohol, non-alcoholic fatty liver disease (NAFLD) and
viral hepatitis.
NAFLD describes the process of hepatic accumulation
of fat, ranging from benign steatosis, via liver inflamma-
tion (steatohepatitis) to progressive liver fibrosis and even-
tually cirrhosis, and can be considered the pathological
manifestation in the liver of the metabolic syndrome. In
addition to type 2 diabetes, hypertension and hypercholes-
terolaemia, high body mass index (BMI) is a significant
driver for NAFLD, and is associated with increased risk of
heart disease and stroke [4]. Although BMI is commonly
used as a measure of body fat, it has been demonstrated
that waist and hip measurements may be stronger predic-
tors of body fat than BMI [5, 6].
We have previously demonstrated the association
between increasing BMI and risk of CLD. In a large
cohort of post-menopausal women we observed more
clinical events attributable to cirrhosis amongst women
who were overweight or obese compared to those with a
normal BMI. Although there was no evidence of signifi-
cant interaction between alcohol and BMI, the highest risk
of liver disease was seen in women who were overweight
or obese and consumed the most alcohol [7].
Skirt size (SS) could be an easily understood surrogate
for BMI to communicate public health messages about
the risks of obesity. Increase in self-reported SS in partici-
pants in the United Kingdom Collaborative Trial of Ovarian
Cancer Screening (UKCTOCS) has been shown to be asso-
ciated with increased breast cancer risk. A unit increase in
UK SS (e.g. 12 to 14) every 10 years between 25 and post-
menopausal age is associated with postmenopausal breast
cancer risk of 33%. Validation of these results could provide
women with a simple and easy to understand message,
using SS [8]. We now explore the association between SS
and change in SS and the incidence of CLD.
Methods
Study population
This prospective cohort study was nested in UKCTOCS,
a UK-based randomised controlled trial investigating the
effect of ovarian cancer screening on mortality. The trial
design is described elsewhere [7–11]; briefly, between
April 2001 and October 2005, post-menopausal women
aged 50–74 in England, Wales and Northern Ireland were
invited at random and 202,638 participants recruited to
the trial. Participants were randomly allocated to one of
three arms (no screening, annual serum CA125 measure-
ment and then transvaginal ultrasound as a second line
test, or ultrasound only). Recent data from the trial have
demonstrated the predictive value of changes in CA125
levels to predict ovarian cancer [12], and reduced mortal-
ity in the multimodal arm [13].
UKCTOCS was approved by the UK North West
Multicentre Research Ethics Committee (North West
MREC 00/8/34). All women provided written consent.
The current study was approved by the National Research
Ethics Service (NRES) Committee London - Bentham
(Ref: 05/Q0505/57) on 10th August 2011.
Exposures
The exposures of interest in this study were BMI and SS
of participants. At the time of recruitment, participants
completed a questionnaire, which included self-reported
height and weight. BMI was calculated (BMI (kg/m2) =
weight (kg)/height (m)2) and categorised according to the
World Health Organization’s definitions; normal (< 25 kg/
m2), overweight (25- < 30 kg/m2) or obese (≥30 kg/m2).
There were some extreme values in self-reported data and
as there are no existing population estimates for the range
of BMI we applied a pragmatic approach in order to in-
clude participants with biologically plausible BMI values.
Therefore, participants were excluded if their reported
height lay outside the range 140–210 cm, or their weight
lay outside the range 25–200 kg, or where the calculated
BMI was outside the range 16–65 kg/m2.
Participants were asked to complete a follow-up ques-
tionnaire 3–5 years post randomisation, and were asked
to estimate their UK SS when they were in their early
twenties and to report their current SS. Using the two
SS responses overall change in SS and change in SS per
year were calculated. In the UK SS range comprises of
even numbers, for example in increase in SS from 12 to
14 is an increase in one UK SS.
Categorisation of exposure variables
BMI was categorised according to World Health
Organization classification as normal, overweight, or
obese. SS was categorised using UK dress sizes as ≤16
and ≥ 18; the latter cut-off selected because of its associ-
ation with an increased risk of cardiovascular morbidity
[14]. The British Standards Institution defines UK size 16
as 100–104 cm, and size 18 as 105–109 cm, measured at
the hips [15]. Change in SS was categorised as decrease,
no change or increase in SS between when participants
were in their early 20s and at their current age.
Covariates
Participants reported, via the follow-up questionnaire,
known comorbidities, comprising hypertension, heart dis-
ease, hypercholesterolaemia, stroke, diabetes, rheumatoid
arthritis, osteoarthritis, osteoporosis (“do you have/are you
being treated for any of the following conditions?”), and
whether they currently smoked, all categorised as yes/no.
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Participants were asked “approximately how much alcohol
on average do you drink each week, assuming one drink =
a glass of wine, half a pint of lager or cider, a measure of
spirits?” This was then categorised as none, < 1–15 units/
week, 16–20 units/week and ≥ 21 units/week, assuming
one drink is equivalent to one UK unit (10 ml or 8 g of
pure alcohol) [16].
Participants were assigned a deprivation score using
the Index of Multiple Deprivation 2007 (IMD) (continu-
ous variable) [17], with a higher score indicating higher
deprivation.
Follow up
Participants in this study were followed through a ‘flagging’
study with NHS Digital which provided data on cancer reg-
istrations and deaths, with diagnosis and/or cause of death
coded according to the International Classification of
Diseases, version 10 (ICD-10). Hospital inpatient and
outpatient data for 2001–10 were also available through
linkage to the Hospital Episodes Statistics (HES) data-
base. Each inpatient HES episode record reports a main
diagnosis and up to 19 additional diagnoses. Outpatient
records report a main diagnosis and up to 11 further
diagnoses. Death records report the primary death code
and additional diagnoses documented on the death certifi-
cate, comprising both ICD-10 codes and free text. Only
participants in England were included in this study, due to
availability of their relevant HES data. Participants entered
the study at the point of return of the follow-up question-
naire, as this was the date that current comorbidities and
SS data were ascertained. Women with pre-existing liver
disease were excluded if a code of interest had been regis-
tered between recruitment to UKCTOCS and return of
follow-up questionnaire.
Outcome
First liver-related event (LRE) was deemed the main out-
come measure. LRE was defined as a participant’s first
presentation of a hospital admission, outpatient appoint-
ment or cancer registration with, or death from, a rele-
vant ICD-10 code. These codes were K70 (alcoholic liver
disease), K73 (chronic hepatitis) and K74 (fibrosis and
cirrhosis) and are consistent with codes employed in other
UK studies of cirrhosis [1, 18]. In addition K76 (other
diseases of the liver, including fat) and codes related to
decompensated liver disease (I85 (oesophageal varices),
Z94.4 (liver transplant) and C22.0 (hepatocellular carcin-
oma)) were included. Death certificates were interrogated
for ICD-10 codes of interest and free text relating to alco-
holic liver disease or fatty liver.
Statistical analysis
For the incidence analyses person-years of follow-up was
used as the denominator. Participants contributed person-
years until the date of censoring (February 1, 2013), date
of first presentation with an LRE or death from any other
cause.
Crude incidence was calculated for each BMI group,
each SS when aged in 20s group, each SS at question-
naire completion group, and change in SS group.
Survival analysis
Potential confounding risk factors including self-reported
comorbidities were analysed in univariate Cox propor-
tional hazards models to determine their individual risks
in liver disease.
Cox proportional hazards models were used to calculate
hazard ratios (HRs) of first LRE, with 95% confidence in-
tervals (CI). For each exposure described above, BMI, SS
when aged in 20s and SS at questionnaire completion
were analysed as continuous coavariates, and then BMI,
SS when aged in 20s, SS at questionnaire completion and
overall change in SS as categorical covariates. For each
outcome, univariate models were produced. Smoking and
deprivation were then added (partially adjusted), and then
all covariates listed above were added, with abstinence and
alcohol consumption ≥21 units/week as individual indica-
tor variables (fully adjusted).
All analyses were performed using SPSS (version 22,
SPSS Inc., Chicago, IL, USA).
Results
Sample characteristics
Of the 157,996 UKCTOCS participants resident in
England, 62,870 were excluded including 321 women
who experienced an LRE or died between recruitment
and return of questionnaire and 14,295 (9%) with no
data on smoking. There was some missing SS data,
and the resulting effective sample size for this study
was 94,124 (Fig. 1).
Overall, 97% of the participants were Caucasian, 36%
were smokers, 55% were overweight (37%) or obese (18%).
Median age at completion of the questionnaire was 64 years.
Baseline characteristics are shown in Table 1.
Distributions of BMI and skirt size
The distributions of BMI, SS when aged in 20s, SS at
questionnaire completion and annual change in SS are
shown in Fig. 2. Median BMI was 25.57 kg/m2 (IQR
22.79–28.36), median SS when aged in 20s was 12 (IQR
10–14), median SS at questionnaire completion was 14
(IQR 12–16), and the median change in SS unit per year
was 0.0323 (IQR 0.0123–0.0523). This is the equivalent
to an increase of one SS unit (e.g. from 12 to 14) every
31 years.
Visual inspection of the histograms (Fig. 2), quantile-
quantile plots and box plots for each outcome variable
showed that each variable was approximately normally
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distributed, but with right-skewness seen with BMI, SS
when aged in 20s and SS at questionnaire completion
(BMI – skewness 1.368 (SE = 0.008), kurtosis 4.033
(SE = 0.016); SS when aged in 20s – skewness 1.442
(SE = 0.008), kurtosis 5.787 (SE = 0.016); SS at question-
naire completion – skewness 0.999 (SE = 0.008), kurtosis
2.415 (SE = 0.016); change in SS per year – skewness 0.470
(SE = 0.008), kurtosis 3.095 (SE = 0.016)).
Crude event rates
Three hundred and twenty two (0.34%) women experi-
enced a first LRE over the follow up period. Crude rates
of LRE are shown in Table 2, categorised by BMI, SS
when aged in 20s, SS at questionnaire completion and
overall change in SS. The most common incident ICD-
10 code was K76 (Additional file 1: Table S1).
The rate of LRE increased with increasing BMI. Com-
parison of rates of LREs in SS categories found a higher
incidence in participants with SS ≥ 18, compared to par-
ticipants with SS ≤ 16, both in the SS when aged in 20s
group and the SS at questionnaire completion group. In
terms of overall change in SS, event rate was lowest in
the group where SS decreased. The rate was higher if
there was no change, and highest if there was an in-
crease in SS (Fig. 3).
Survival analysis
Cox proportional model estimates for each potential
confounder
There were significant associations between LRE and smok-
ing, deprivation, BMI, heart disease, hypercholesterolaemia,
diabetes, rheumatoid arthritis, alcohol abstinence and alco-
hol excess (≥21 units/week) (Additional file 1: Table S2). A
“J-shaped” relationship between alcohol and risk of CLD is
seen, and we have previously explored this finding in the
UKCTOCS population [7].
Cox proportional model estimates for each exposure
When SS when aged in 20s ≥18 was compared to ≤16,
HR for LRE was increased in the unadjusted (HR = 1.81
Fig. 1 Composition of the final study cohort and its derivation from the UKCTOCS cohort
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(95% CI; 1.14–2.87)), partially adjusted (HR = 1.68 (95% CI;
1.06–2.68)) and fully adjusted (HR = 1.39 (95% CI; 0.87–
2.23)) models. The confidence interval for the fully adjusted
model crossed unity, suggesting that a component of the
risk may be partially attributable to one or more of the
metabolic comorbidities (hypertension, hypercholesterol-
aemia, diabetes and heart disease) (Table 3). Comparing the
two SS groups at questionnaire completion, HRs were again
higher in the higher SS group in all models (HR = 1.69
(95% CI; 1.34–2.13) in the unadjusted model, HR = 1.58
(95% CI; 1.25–2.00) in the partially adjusted model, HR =
1.37 (95% CI; 1.07–1.75) in the fully adjusted model).
Compared to women whose SS decreased between their
20s and questionnaire completion, HRs were higher in
those whose SS did not change and highest in those whose
SS increased (Table 3).
Compared to normal BMI, overweight and obesity were
significantly associated with LRE in all models (Table 3).
Discussion
Main findings
We have demonstrated in a cohort of post-menopausal
women that a larger SS is associated with subsequent
risk of LRE, and a SS of ≥18 compared to a SS of ≤16 is
associated with a higher HR than that associated with
overweight, but less than that associated with obesity
when compared to a normal BMI. Although the risks of
high SS and high BMI may not be directly comparable,
the value of communicating public health messages in
terms of SS lies in better understanding amongst the
general public compared to communicating the risk of
liver disease associated with increased BMI.
Table 1 Baseline characteristics and number of first events according to BMI category, and for all participants
Characteristic BMI category (kg/m2) All
participants< 25 25 - < 30 ≥18
Total, n (% of all participants) 42, 077 (44.7) 34,690 (36.9) 17,260 (18.3) 94,124
LRE, n (% of all participants) 102 (31.7) 123 (38.2) 97 (30.1) 322
Age at questionnaire return, median years (range) 63 (52–80) 64 (53–80) 64 (53–80) 64 (52–80)
IMD, mean (SD) 17.0 (13.1) 18.7 (14.1) 21.3 (15.4) 18.4 (14.0)
Smoker, n (%) 14,632 (34.8) 12,511 (36.1) 6548 (37.7) 33,691 (35.8)
Hypertension, n (%) 9382 (22.3) 11,970 (34.5) 8307 (47.9) 29,659 (31.5)
Heart disease, n (%) 1698 (4.0) 2052 (5.9) 1392 (8.0) 5142 (5.5)
Hypercholesterolaemia, n (%) 7901 (18.8) 9044 (26.1) 5369 (30.9) 22,314 (23.7)
Stroke, n (%) 523 (1.2) 552 (1.6) 314 (1.8) 1389 (1.5)
Diabetes, n (%) 827 (2.0) 1653 (4.8) 2221 (12.8) 4701 (5.0)
Rheumatoid arthritis, n (%) 1592 (3.8) 1742 (5.0) 1185 (6.8) 4519 (4.8)
Osteoarthritis, n (%) 5503 (13.1) 5822 (16.8) 4016 (23.1) 15,341 (16.3)
Osteoporosis, n (%) 3808 (9.1) 2082 (6.0) 770 (4.4) 6660 (7.1)
Alcohol consumption (units/week), n (%)
None 8365 (19.9) 8.043 (23.2) 5432 (31.3) 21,840 (23.2)
< 1–15 31,567 (75.0) 25,095 (72.3) 11,347 (65.4) 68,009 (72.3)
16–20 1436 (3.4) 1063 (3.1) 364 (2.1) 2863 (3.0)
≥ 21 709 (1.7) 489 (1.4) 214 (1.2) 1412 (1.5)
Skirt size when aged in 20s, n (%)
≤ 16 41,428 (98.5) 33,835 (97.5) 15,691 (90.4) 90,954 (96.6)
≥ 18 649 (1.5) 855 (2.5) 1666 (9.6) 3170 (3.4)
Skirt size at time of questionnaire completion, n (%)
≤ 16 40,792 (96.9) 26,982 (77.8) 4481 (25.8) 72,255 (76.8)
≥ 18 1285 (3.1) 7708 (22.2) 12,876 (74.2) 21,869 (23.2)
Change in skirt size, median (interquartile range) 0.0244 (0.03) 0.0408 (0.04) 0.0667 (0.05) 0.0323 (0.04)
Overall change in skirt size, n (%)
Decrease 4811 (11.4) 1153 (3.3) 362 (2.1) 6326 (6.7)
No change 12,344 (29.3) 3422 (9.9) 731 (4.2) 16,497 (17.5)
Increase 24,922 (59.2) 30,115 (86.8) 16,264 (93.7) 71,301 (75.8)
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In our cohort, 76% reported an increase in SS between
when aged in 20s and questionnaire completion. This is
consistent with previous studies reporting the change in
body composition associated with transitioning from
pre-menopausal to post-menopausal status, with an in-
crease in central adiposity manifested by increased waist
circumference (WC) [19].
When BMI and SS (as continuous variables) were
combined, the HR for each was reduced, suggesting that
SS (and BMI) is an independent predictor for NAFLD,
and that SS may reflect centripetal fat distribution asso-
ciated with NAFLD better than BMI.
NAFLD is poorly identified in primary care and it is
conceivable that a proportion of individuals with LREs
that were not associated with an ICD-10 code for fatty
liver may have had NAFLD. SS may be a better predictor
of NAFLD (obesity) related liver disease than a clinical
diagnosis of NAFLD in primary care.
Although the codes or text contributing most com-
monly to LRE were those representing NAFLD, those
representing alcoholic liver disease contributed to nearly
10% of LREs (Additional file 1: Table S1). Regardless of
the aetiology of CLD, the clinicopathological pathway is
progressive fibrosis leading to cirrhosis [20] and there
may be common pathways in which alcohol and BMI
damage the liver [21]. Patterns of alcohol consumption
in women are changing; 16% of women in England con-
sume above recommended limits, and this practice is
highest in the 55–64 year old group [22], and the rate of
alcohol-related hospital admissions by women increased
by over 30% between 2008 and 2015 [23].
Strengths and limitations
Strengths of this study include the large size of the cohort,
the prospective design and the independence of data cap-
ture for outcomes. We used ICD-10 codes for cirrhosis
a b
c d
Fig. 2 Distributions of a) BMI, b) skirt size in 20s, c) skirt size at questionnaire completion, and d) change in skirt size per year
Table 2 Crude rates of liver-related event. Events per 1000
participant years (95% confidence intervals)
Exposure Event rate
BMI (kg/m2) < 25 0.453 (0.369–0.550)
25- < 30 0.661 (0.549–0.788)
≥30 1.044 (0.847–1.273)
Skirt size in 20s ≤ 16 0.621 (0.553–0.696)
≥ 18 1.124 (0.677–1.755)
Skirt size at questionnaire completion ≤ 16 0.550 (0.479–0.629)
≥ 18 0.928 (0.762–1.120)
Change in skirt size/year Decrease 0.3867 (0.206–0.661)
No change 0.599 (0.449–0.784)
Increase 0.669 (0.590–0.757)
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that have been used in other studies, but in an attempt to
maximise the ability to identify liver disease we also in-
cluded codes relating to clinical consequences of advanced
cirrhosis, the events defining decompensated liver disease.
Evaluation of numerous possible confounders including
self reported known comorbidities and socioeconomic sta-
tus minimised bias.
Limitations include the reliance of self-reporting of SS,
height and weight and co-morbidities. There is some evi-
dence supporting the reliability of self-reporting of bio-
metric data including height and weight [24–28], notably
in a longitudinal study of older people [29]. There was a
30–50 year recall of participants’ SS when aged in their
20s, raising the possibility of recall error. Several studies
have demonstrated good accuracy in recalled weight, with
some data indicating underestimation in those with higher
BMI [30–33]. We postulate that participants may have a
better recollection of their skirt size than their weight or
waist size. There was a 25 year age range in participants,
and older participants may have had children at a younger
age than younger participants, which may have increased
their SS [34].
It is likely that there will be some variability between
SS over the period between the two SS estimates. In the
UK there is no requirement for manufacturers to adhere
to the standard sizing. In addition the phenomenon of
vanity sizing is recognised, where clothes with the same
size label have become larger over recent decades. This
has become a common practice of clothing manufac-
turers, which may potentially impede comparisons of
sizes over time [35]. Indeed, the Chief Medical Officer
for England has highlighted this ‘size inflation’ as a risk
for society normalising overweight [36].
Reliance on ICD-10 to define events may result in errors
due to mis-coding. We used three independent sources in
an attempt to reduce risk of non-coding. Further, HES
data may not capture some areas of healthcare, including
the private sector. Finally, although attempts were made
to ensure UKCTOCS was representative of the general
population, there was a ‘healthy volunteer effect’ on over-
all and cause-specific mortality, which may affect the gen-
eralisability of our findings [17].
Other studies
The link between obesity and the risk of NAFLD is strong,
with a clear dose-response relationship demonstrated in
cross-sectional studies [37], although data from prospect-
ive studies are limited [38, 39].
However, few studies have investigated the relationship
between SS and disease. Ours is the only study we are
aware of that has investigated the association between SS
and liver disease. The UKCTOCS group demonstrated an
increase in risk of breast cancer with increase in SS over
time [12].
A study nested in the Netherlands Cohort Study on
Diet and Cancer reported increased risk of endometrial
cancer with increasing SS. The correlation between self-
reported SS and self-reported WC, self-reported hip cir-
cumferences and BMI based on self-reported height and
weight in 1334 women, were 0.71, 0.78 and 0.76 respect-
ively [40].
A study of 293 men and women found that professionally
measured WC correlated closely with clothing size in both
men and women (r = 0.80 and 0.78, respectively) [41].
Fig. 3 Crude rates of LRE per 1000 person years, for a) BMI, b) skirt
size in 20s, c) skirt size at questionnaire completion and d) change
in skirt size
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Table 3 Hazard ratios of first events for skirt size in 20s, skirt size at questionnaire completion, BMI and change in skirt size (95%
confidence intervals and p values)
Variable Hazard ratio (95% CI)
Skirt size when aged in 20s Univariate Continuous 1.062 (1.022–1.104)
p = 0.002
Categorical ≤ 16 Reference
≥ 18 1.806 (1.136–2.871)
p = 0.012
Adjusted for smoking, deprivation ≤ 16 Reference
≥ 18 1.681 (1.057–2.675)
p = 0.028
Adjusted for age, smoking, deprivation, hypertension,
heart disease, hypercholesterolaemia, stroke, diabetes,
rheumatoid arthritis, osteoarthritis, osteoporosis,
alcohol abstinence, alcohol ≥21 units/week
≤ 16 Reference
≥ 18 1.390 (0.868–2.226)
p = 0.171
Skirt size at time of questionnaire
completion
Univariate Continuous 1.091 (1.062–1.121)
p < 0.0005
Categorical ≤ 16 Reference
≥ 18 1.690 (1.342–2.129)
p < 0.0005
Adjusted for smoking, deprivation ≤ 16 Reference
≥ 18 1.579 (1.250–1.995)
p < 0.0005
Adjusted for age, smoking, deprivation, hypertension,
heart disease, hypercholesterolaemia, stroke, diabetes,
rheumatoid arthritis, osteoarthritis, osteoporosis, alcohol
abstinence, alcohol ≥21 units/week
≤ 16 Reference
≥ 18 1.369 (1.071–1.749)
p = 0.012
BMI (kg/m2) Univariate Continuous 1.063 (1.044–1.082)
p < 0.0005
Categorical < 25 Reference
≥ 25 - < 30 1.461 (1.123–1.899)
p = 0.005
≥ 30 2.308 (1.748–3.047)
p < 0.0005
Adjusted for smoking, deprivation < 25 Reference
≥ 25 - < 30 1.403 (1.076–1.830)
p = 0.012
≥ 30 2.162 (1.631–2.864)
p < 0.0005
Adjusted for age, smoking, deprivation, hypertension,
heart disease, hypercholesterolaemia, stroke, diabetes,
rheumatoid arthritis, osteoarthritis, osteoporosis,
alcohol abstinence, alcohol ≥21 units/week
< 25 Reference
≥ 25 - < 30 1.353 (1.034–1.770)
p = 0.028
≥ 30 1.880 (1.395–2.533)
p < 0.0005
Change in skirt size/year Univariate Categorical Decrease Reference




Adjusted for smoking, deprivation Decrease Reference
No change 1.714 (0.915–3.211)
p = 0.092
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Similarly, a study nested in the fourth Glasgow monitor-
ing cardiovascular (MONICA) disease risk factor survey
measured height, weight, WC and hip circumference, and
obtained SS in 161 women. Dress size correlated with WC
and BMI. Dress size ≥18 was associated with a signifi-
cantly increased risk of cardiovascular disease [14].
Conclusion
We have demonstrated that SS in middle age is associ-
ated with increased risk of CLD. In post-menopausal
women who develop liver disease, there is a significantly
higher average SS when aged in their 20s (and in middle
age). If these results are confirmed in further population
studies, this may provide a simple way for women to
stratify their risk of liver disease.
Additional file
Additional file 1: Table S1. ICD-10 codes and death certificate text of
first LREs. Summary of the ICD-10 code(s) representing first presentation
of liver-related event. Table S2. Hazard ratios for liver-related events for
potential confounders (95% confidence intervals and p values). Univariate
hazard ratios for liver-related events for smoking, deprivation, alcohol
categories, alcohol ≥21 units/week, abstinence from alcohol, BMI,
hypertension, heart disease, hypercholesterolaemia, stroke, diabetes,
rheumatoid arthritis, osteoarthritis, osteoporosis. (DOCX 95 kb)
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